Eyluxvi 40mg / ml Solution for injection in vial

Licence status
Authorised: 15/09/2025
Active substances
Aflibercept
Dosage Form
Solution for injection in vial
Licence number
EU/1/25/1972/001
Licence holder
Biolitec Pharma Limited

Product documents

Licence information

ATC code
S01LA05 aflibercept
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/09/2025